From Medscape Diabetes & Endocrinology

Coverage from the

European Association for the Study of Diabetes (EASD) 2020 Annual Meeting

September 21 - 25, 2020; Virtual

September 21 - 25, 2020 Virtual

EASD 2020 'Modest' Benefit for Post-MI Flash Glucose Monitoring in T2D Following a heart attack, there appears to be a 'modest' benefit of using flash glucose monitoring over fingerstick testing in patients with type 2 diabetes being treated with insulin or a sulfonylurea.
Medscape Medical News, October 21, 2020
EASD 2020 Diabetic Neuropathic Pain Linked to Brain Bioenergic Anomalies Abnormal mitochondrial activity in the somatosensory cortex and right thalamus may explain why some patients with type 2 diabetes experience painful peripheral neuropathy, suggest findings of a UK study.
Medscape Medical News, October 20, 2020
EASD 2020 Substance in Tears Could Be Used for Diabetes Monitoring Glycated albumin levels in tears strongly correlated with blood levels in a small trial.
Medscape Medical News, October 19, 2020

Conference News

EASD 2020 'Modest' Benefit for Post-MI Flash Glucose Monitoring in T2D
Medscape Medical News, October 21, 2020
EASD 2020 Diabetic Neuropathic Pain Linked to Brain Bioenergic Anomalies
Medscape Medical News, October 20, 2020
EASD 2020 Substance in Tears Could Be Used for Diabetes Monitoring
Medscape Medical News, October 19, 2020
EASD 2020 What Is the Best First-Line Therapy for Type 2 Diabetes?
Medscape Medical News, October 14, 2020
EASD 2020 'On-Demand' Fast Mobilizes Fat; Low-Carb Breakfast Stymies Hunger
Medscape Medical News, October 12, 2020
EASD 2020 Emerging Data on Type 1 Diabetes and COVID-19 Reassuring
Medscape Medical News, October 9, 2020
EASD 2020 Novel Dual-Hormone 'Artificial Pancreas' Is Promising
Medscape Medical News, October 6, 2020
EASD 2020 Time to Screen for Liver Disease in Type 2 Diabetes?
Medscape Medical News, October 6, 2020
EASD 2020 Call to Action for Screening, Early Treatment of Diabetes
Medscape Medical News, October 1, 2020
EASD 2020 Diabetes Remission After Bariatric Surgery Best in Those Not on Insulin
Medscape Medical News, September 30, 2020
EASD 2020 Ethnic Minorities Affected Most in Rise of Early Onset T2 Diabetes
Medscape News UK, September 30, 2020
EASD 2020 Exercise Cuts Diabetes Death Risk by a Third
Medscape Medical News, September 29, 2020
EASD 2020 Higher 'Time in Range' May Benefit Type 2 Diabetes Patients
Medscape Medical News, September 29, 2020
EASD 2020 Post-COVID-19, Type 1 Diabetes Patients Will Stick With Telemedicine
Medscape Medical News, September 29, 2020

EASD 2020 Insulins Detemir and Glargine Safe in Diabetes Pregnancies
Medscape Medical News, September 28, 2020
EASD 2020 DAPA-CKD Resets eGFR Floor for Safe SGLT2 Inhibitor Use
Medscape Medical News, September 25, 2020
EASD 2020 British Protocol Allows Insulin-Treated Pilots to Fly Safely
Medscape Medical News, September 25, 2020
EASD 2020 Thousands of Undiagnosed T2D Cases Found in UK Biobank Cohort
Medscape News UK, September 25, 2020
EASD 2020 VERTIS CV: Ertugliflozin Benefit Falls Short of Other SGLT2 Inhibitors
Medscape Medical News, September 25, 2020
EASD 2020 Hot Tubs Improve A1c, BMI, and Blood Pressure in Type 2 Diabetes
Medscape Medical News, September 24, 2020
EASD 2020 Type 2 Diabetes Remission Can Restore Pancreas Morphology
Medscape News UK, September 24, 2020
EASD 2020 Four Times As Many Life Years Lost to T1D Than T2D
Medscape News UK, September 24, 2020
EASD 2020 Second-Generation Immigrants With Diabetes Fare Worse Than Natives
Medscape Medical News, September 24, 2020
EASD 2020 Vascular Dementia Risk Particularly High in Type 2 Diabetes
Medscape Medical News, September 23, 2020
EASD 2020 Survival After Kidney Transplantation Lags in Diabetes Patients
Medscape Medical News, September 23, 2020
EASD 2020 Once-Weekly Insulin Data Published; It Could Alter Treatment
Medscape Medical News, September 22, 2020
EASD 2020 For Better, for Worse? Couples' Lifestyles Impact Diabetes Risk
Medscape Medical News, September 22, 2020
EASD 2020 Type 2 Diabetes Drugs and Their Use Are Top of EASD Agenda
Medscape Medical News, September 16, 2020

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

GLP-1 Receptor Agonists at EASD 2020: Poster Pearls
Akshay B. Jain, MD
New Diabetes Guidelines: 'Treat to Mitigate'
Akshay B. Jain, MD
What Is LADA and How Should We Treat It?
Anne L. Peters, MD
'Good News' From the FDA: Label Changes for Dulaglutide, Canagliflozin
Anne L. Peters, MD
Insulin Updates From EASD 2020
Anne L. Peters, MD
EASD Highlights: Hypoglycaemia & Guidelines Consensus
Prof Kamlesh Khunti
EASD Science: Beta Cells in the Eyes for T1D
Professor Guy Rutter
Once-Weekly 'Centennial Insulin': Will It Live Up to the Promise?
Harpreet S. Bajaj, MD, MPH

Previous Coverage

EASD 2019

Popular News from EASD 2019

FDA OKs 'Game-Changer' Oral GLP-1 Agonist for Type 2 Diabetes Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake.
Medscape Medical News, Sep 20, 2019
CGM, Not Insulin Pump, 'Is What Makes Difference' in Type 1 Diabetes "It is not so important how insulin is delivered, but more important is how patients with type 1 diabetes monitor their glucose," says the author of the longest running study comparing different approaches.
Medscape Medical News, Sep 18, 2019
Vegan Diet Alters Microbiome and Insulin Sensitivity, Drops Weight Adopting a vegan diet seems to alter the gut microbiome and improve insulin sensitivity with associated weight loss, compared to eating conventionally even with no direction to restrict calorie intake.
Medscape Medical News, Sep 17, 2019